ANI Pharmaceuticals-ANI (ANIP) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2024, ANI Pharmaceuticals (ANIP) reported revenue of $190.57 million, up 44.8% over the same period last year. EPS came in at$ 1.63, compared to $1.00 in the year-ago quarter.The reported revenue represents a surprise of +8.98% over the Zacks Consensus Estimate of$ 174.88 million. With the consensus EPS estimate being $1.44, the EPS surprise was +13.19%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to W ...